DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Quan Capital Management, LLC
Quan Capital Management, LLC
Institutional venture firmGrand Caymanquancapital.comSEC venture capital fund adviserone firm, 2 filing advisers
This firm files as 2 advisers on quancapital.com: Quan Capital Management (US) LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager, reported GAV $342M across 3 vehicles
Importance
22
moderate
Active deployment
4
low
Emerging
0
low
Completeness
56
elevated
Freshness
100
high
Research priority
6
low
Identity and regulatory footprint
- Headquarters
- Grand Cayman, Cayman Islandsadviserinfo.sec.gov
- Office address
- C/O MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, Grand Cayman, KY1-1104adviserinfo.sec.gov
- Business phone
- 345-949-8066adviserinfo.sec.gov
- Website
- https://www.quancapital.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 28, 2024
- Private funds reported
- 3 (3 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $342Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Actx LLC (Member), E; Acts Consulting Limited (Member), B; MWY LLC (Member), B; Sheng LLC (Member), D
- business phone
- 345-949-8066adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Sectors
unknown 100%
lead rate 0%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
3 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Quan Venture Fund III, L.P. | Fund | 2022 adv first reported | Active deployment | $57.1M Mar 28, 2024 | 60 | $0 of $350M | Aug 30, 2021 |
| Quan Venture Fund II, L.P. | Fund | 2019 adv first reported | Mature | $217M Mar 28, 2024 | 70 | $0 of $300M | Aug 30, 2018 |
| Quan Venture Fund I, L.P. | Fund | unknown | Unknown | $68.1M Mar 28, 2024 | 35 | $0 of $150M | May 19, 2017 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
3 current, 0 departed
Marietta Wu
PartnerMember And Manager · since May 1, 2018
Stella X Xu
PartnerMember And Manager · since May 1, 2018
Ying du
PartnerSole Manager · since Apr 1, 2017
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics | Series B · Series B | participant | unknown | $89.0M | unknown | Mar 26, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
5 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
- Mar 21, 2022Quan Venture Fund III, L.P. first reported on Form ADV by Quan Capital Management, LLC (Venture Capital Fund), GAV $112,850,000Fund first reported on Form ADVFundsFactQuan Venture Fund III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 2, 2019Quan Venture Fund II, L.P. first reported on Form ADV by Quan Capital Management, LLC (Venture Capital Fund), GAV $100,000,000Fund first reported on Form ADVFundsFactQuan Venture Fund II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- May 1, 2018Stella X Xu joined Schedule A of Quan Capital Management, LLC as Member
- Jan 31, 2018Quan Capital Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 31, 2018Quan Venture Fund I, L.P. first reported on Form ADV by Quan Capital Management, LLC (Venture Capital Fund), GAV $146,600,000Fund first reported on Form ADVFundsFactQuan Venture Fund I, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $342M across 3 vehicles
Evidence
25 observations from 2 sources